Intracavitary tumors, including those originating from the respiratory tract, gastrointestinal (GI) tract, and urinary tract, mainly consist of epithelial cancers sharing similar characteristics, such ...
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state's first ...
Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...
Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.
The evidence-backed model delivered impressive results, but it doesn’t validate the wave of AI therapy bots flooding the ...
UVA Health recently joined two national clinical trials that are part of the National Institutes of Health’s Researching ...
BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...
Lenny Santoro was diagnosed with prostate cancer in 2011. Thanks to clinical trials Santoro participated in at the Duke ...
Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...
Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...
1dOpinion
Ending clinical trials with no warning can put patients at risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback